Chapter 127: Bronchopulmonary Dysplasia (BPD)

Chronic lung disease of prematurity ยท Definition (NICHD 2018) ยท Pathophysiology (new BPD) ยท Prevention (CPAP, caffeine, gentle ventilation) ยท Treatment (diuretics, bronchodilators, steroids, pulmonary hypertension)
๐Ÿซ Key fact: ~60% of infants โ‰ค28 wk develop BPD; severity correlates with neurodevelopmental impairment and long-term respiratory morbidity.

๐Ÿซ Bronchopulmonary Dysplasia: Core Concepts

๐Ÿ“Š Incidence & definition
~60% at โ‰ค28 wk. NICHD 2018: mild (room air), moderate (<30% O2), severe (โ‰ฅ30% O2 or PPV) at 36 wk PMA. Grade III(A) for lethal BPD.
๐Ÿงฌ Pathophysiology (new BPD)
Arrested alveolarization + dysregulated microvascular development. Inflammation, volutrauma, oxygen toxicity, PDA, infection.
๐Ÿ›ก๏ธ Prevention strategies
Early CPAP, INSURE/LISA, caffeine, gentle ventilation (volume-targeted), avoid hyperoxia, treat PDA, optimal nutrition.
๐Ÿ’Š Treatment (supportive)
Diuretics (furosemide, chlorothiazide) for pulmonary edema. Bronchodilators (albuterol) for airway reactivity. Pulmonary hypertension therapy (iNO, sildenafil).
โš ๏ธ Systemic corticosteroids
Dexamethasone improves extubation but increases CP risk; reserve for severe ventilator-dependent infants after 7-14 days with high BPD risk.
๐Ÿ“ˆ Prognosis
BPD โ†’ neurodevelopmental impairment, asthma-like symptoms, pulmonary hypertension, rehospitalizations. Lung function improves slowly over childhood.
โšก Major complications: Pulmonary hypertension (15-40% severe BPD), subglottic stenosis, tracheomalacia, vocal cord paralysis, cor pulmonale, growth failure, ROP.

๐Ÿ” Approach to the preterm infant at risk for BPD

1
Identify high-risk infants โ€“ GA <28 wk, birthweight <1000 g, prolonged mechanical ventilation, severe RDS, PDA, sepsis, NEC.
2
Monitor respiratory status โ€“ Persistent oxygen requirement beyond 28 days, tachypnea, retractions, crackles, hypercapnia, need for PPV or CPAP at 36 wk PMA.
3
Assess for pulmonary hypertension โ€“ Echocardiogram in all moderate-severe BPD to evaluate RV pressure, septal flattening, and right heart function.
4
Rule out other causes โ€“ Airway anomalies (subglottic stenosis, tracheomalacia, vocal cord paralysis), gastroesophageal reflux, aspiration, CHD.
5
Grade severity at 36 wk PMA โ€“ Mild (room air), moderate (<30% O2), severe (โ‰ฅ30% O2 and/or PPV). Use for prognosis and management planning.

๐Ÿ“‹ Stepwise management of established BPD

1
Optimize lung growth & nutrition โ€“ Aggressive nutrition (120-130 kcal/kg/day), human milk fortification, monitor growth (weight, length, head circumference). Vitamin A may reduce BPD.
2
Respiratory support weaning โ€“ Gradual reduction of FiO2, CPAP (or noninvasive ventilation) to maintain FRC. Caffeine continued until stable off respiratory support.
3
Diuretics for pulmonary edema โ€“ Furosemide (1 mg/kg IV/PO) or chlorothiazide. Short-term improvement but long-term risks (nephrocalcinosis, electrolyte disturbances).
4
Bronchodilators for reactive airways โ€“ Inhaled albuterol (2.5 mg nebulized) for wheezing/BPD spells. Ipratropium bromide may be added.
5
Pulmonary hypertension management โ€“ Maintain SpO2 92-96%, avoid hypoxia. Inhaled nitric oxide (iNO) for acute exacerbations. Sildenafil (1 mg/kg q8h) for chronic PH; consider prostacyclin analogs.
6
Systemic corticosteroids (limited use) โ€“ Low-dose dexamethasone (0.89 mg/kg cumulative over 10 days) for ventilator-dependent infants at high risk of death/severe BPD after 7-14 days. Monitor for hyperglycemia, hypertension, cardiomyopathy.
๐Ÿ“Œ BPD spells: Acute hypoxemia/bradycardia due to airway obstruction (mucus plug, bronchospasm) or pulmonary hypertension. Manage with suction, bronchodilators, sedation, optimize PEEP.

๐Ÿง  Rapid reflex prompts โ€“ Bronchopulmonary Dysplasia

๐Ÿ“Œ Definition of severe BPD (NICHD 2018)?
At 36 wk PMA: need for โ‰ฅ30% oxygen and/or positive pressure ventilation.
๐Ÿ“Œ Most effective prevention for BPD?
Early CPAP + selective surfactant (INSURE/LISA) + caffeine + gentle ventilation.
๐Ÿ“Œ When to consider systemic steroids for BPD?
Ventilator-dependent after 7-14 days with high risk of death/severe BPD; low cumulative dose dexamethasone.
๐Ÿ“Œ Which medication reduces BPD and improves neurodevelopment?
Caffeine citrate (started for apnea of prematurity).
๐Ÿ“Œ Complication of long-term furosemide in BPD?
Nephrocalcinosis, cholelithiasis, ototoxicity, electrolyte disturbances.
๐Ÿ“Œ Pulmonary hypertension in BPD: treatment?
Oxygen (SpO2 92-96%), sildenafil, iNO for acute, treat underlying lung disease.